Dolby Laboratories, Inc. (DLB) Major Shareholder Dagmar Dolby Sells 50,000 Shares

Share on StockTwits

Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 50,000 shares of the firm’s stock in a transaction that occurred on Monday, July 2nd. The stock was sold at an average price of $61.23, for a total transaction of $3,061,500.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Thursday, June 28th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $61.93, for a total transaction of $6,193,000.00.
  • On Tuesday, June 26th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.17, for a total transaction of $6,217,000.00.
  • On Friday, June 22nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $64.55, for a total transaction of $6,455,000.00.
  • On Wednesday, June 20th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.22, for a total transaction of $3,261,000.00.
  • On Monday, June 18th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.31, for a total transaction of $6,531,000.00.
  • On Thursday, June 14th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $64.87, for a total transaction of $6,487,000.00.
  • On Monday, June 11th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $64.31, for a total transaction of $3,215,500.00.
  • On Friday, June 8th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $64.25, for a total transaction of $3,212,500.00.
  • On Wednesday, June 6th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $64.36, for a total transaction of $3,218,000.00.
  • On Monday, June 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.93, for a total transaction of $6,293,000.00.

Shares of Dolby Laboratories traded down $0.11, hitting $61.58, during midday trading on Monday, according to MarketBeat Ratings. 209,100 shares of the stock traded hands, compared to its average volume of 408,796. Dolby Laboratories, Inc. has a 1-year low of $48.00 and a 1-year high of $74.29. The company has a market cap of $6.42 billion, a price-to-earnings ratio of 27.99, a price-to-earnings-growth ratio of 2.23 and a beta of 0.74.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Tuesday, April 24th. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.64 by $0.14. Dolby Laboratories had a net margin of 7.64% and a return on equity of 12.73%. The company had revenue of $301.36 million during the quarter, compared to the consensus estimate of $300.37 million. During the same quarter in the previous year, the company posted $0.63 earnings per share. The company’s revenue for the quarter was up 12.7% compared to the same quarter last year. equities analysts expect that Dolby Laboratories, Inc. will post 2.31 EPS for the current fiscal year.

Institutional investors and hedge funds have recently made changes to their positions in the company. Elkfork Partners LLC acquired a new position in shares of Dolby Laboratories during the fourth quarter valued at $102,000. Captrust Financial Advisors acquired a new position in shares of Dolby Laboratories during the fourth quarter valued at $122,000. Cornerstone Capital Management Holdings LLC. acquired a new position in shares of Dolby Laboratories during the fourth quarter valued at $145,000. Meadow Creek Investment Management LLC acquired a new position in shares of Dolby Laboratories during the fourth quarter valued at $179,000. Finally, Commonwealth Equity Services LLC acquired a new position in shares of Dolby Laboratories during the first quarter valued at $203,000. 53.90% of the stock is owned by institutional investors.

A number of equities analysts have commented on the stock. Barrington Research reaffirmed a “buy” rating and issued a $78.00 price objective on shares of Dolby Laboratories in a report on Tuesday, May 1st. Zacks Investment Research raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating and set a $73.00 price objective for the company in a report on Wednesday, March 28th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $66.50.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply